Literature DB >> 18491928

99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer.

Jiyun Shi1, Bing Jia, Zhaofei Liu, Zhi Yang, Zilin Yu, Kai Chen, Xiaoyuan Chen, Shuang Liu, Fan Wang.   

Abstract

In this report, we present the synthesis and evaluation of the (99m)Tc-labeled beta-Ala-BN(7-14)NH2 (ABN = beta-Ala-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2) as a new radiotracer for tumor imaging in the BALB/c nude mice bearing HT-29 human colon cancer xenografts. The gastrin releasing peptide receptor binding affinity of ABN and HYNIC-ABN (6-hydrazinonicotinamide) was assessed via a competitive displacement of (125)I-[Tyr4]BBN bound to the PC-3 human prostate carcinoma cells. The IC 50 values were calculated to be 24 +/- 2 nM and 38 +/- 1 nM for ABN and HYNIC-ABN, respectively. HYNIC is the bifunctional coupling agent for (99m)Tc-labeling, while tricine and TPPTS (trisodium triphenylphosphine-3,3',3''-trisulfonate) are used as coligands to prepare the ternary ligand complex [(99m)Tc(HYNIC-ABN)(tricine)(TPPTS)] in very high yield and high specific activity. Because of its high hydrophilicity (log P = -2.39 +/- 0.06), [(99m)Tc(HYNIC-ABN)(tricine)(TPPS)] was excreted mainly through the renal route with little radioactivity accumulation in the liver, lungs, stomach, and gastrointestinal tract. The tumor uptake at 30 min postinjection (p.i.) was 1.59 +/- 0.23%ID/g with a steady tumor washout over the 4 h study period. As a result, it had the best T/ B ratios in the blood (2.37 +/- 0.68), liver (1.69 +/- 0.41), and muscle (11.17 +/- 3.32) at 1 h p.i. Most of the injected radioactivity was found in the urine sample at 1 h p.i., and there was no intact [(99m)Tc(HYNIC-ABN)(tricine)(TPPTS)] detectable in the urine, kidney, and liver samples. Its metabolic instability may contribute to its rapid clearance from the liver, lungs, and stomach. Despite the steady radioactivity washout, the tumors could be clearly visualized in planar images of the BALB/c nude mice bearing the HT-29 human colon xenografts at 1 and 4 h p.i. The favorable excretion kinetics from the liver, lungs, stomach, and gastrointestinal tract makes [(99m)Tc(HYNIC-ABN)(tricine)(TPPTS)] a promising SPECT radiotracer for imaging colon cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18491928     DOI: 10.1021/bc700471z

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  13 in total

1.  Specific targeting of human integrin α(v)β (3) with (111)In-labeled Abegrin™ in nude mouse models.

Authors:  Zhaofei Liu; Bing Jia; Huiyun Zhao; Xiaoyuan Chen; Fan Wang
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

Review 2.  Bombesin receptor-mediated imaging and cytotoxicity: review and current status.

Authors:  Veronica Sancho; Alessia Di Florio; Terry W Moody; Robert T Jensen
Journal:  Curr Drug Deliv       Date:  2011-01       Impact factor: 2.565

Review 3.  Radiolabeled bombesin derivatives for preclinical oncological imaging.

Authors:  Carolina de Aguiar Ferreira; Leonardo Lima Fuscaldi; Danyelle M Townsend; Domenico Rubello; André Luís Branco de Barros
Journal:  Biomed Pharmacother       Date:  2016-12-29       Impact factor: 6.529

Review 4.  Optical imaging-guided cancer therapy with fluorescent nanoparticles.

Authors:  Shan Jiang; Muthu Kumara Gnanasammandhan; Yong Zhang
Journal:  J R Soc Interface       Date:  2009-09-16       Impact factor: 4.118

5.  LC/MS evaluation of metabolism and membrane transport of bombesin peptides.

Authors:  Dongyu Gu; Ying Ma; Gang Niu; Yongjun Yan; Lixin Lang; Haji Akber Aisa; Haji Akber Aisaand; Haokao Gao; Dale O Kiesewetter; Xiaoyuan Chen
Journal:  Amino Acids       Date:  2010-07-30       Impact factor: 3.520

Review 6.  Radiopharmaceutical development of radiolabelled peptides.

Authors:  Melpomeni Fani; Helmut R Maecke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

Review 7.  Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment.

Authors:  Paola Moreno; Irene Ramos-Álvarez; Terry W Moody; Robert T Jensen
Journal:  Expert Opin Ther Targets       Date:  2016-03-28       Impact factor: 6.902

8.  A new 18F-labeled BBN-RGD peptide heterodimer with a symmetric linker for prostate cancer imaging.

Authors:  Yongjun Yan; Kai Chen; Min Yang; Xilin Sun; Shuanglong Liu; Xiaoyuan Chen
Journal:  Amino Acids       Date:  2010-10-10       Impact factor: 3.520

9.  Evaluation of fluorine-labeled gastrin-releasing peptide receptor (GRPR) agonists and antagonists by LC/MS.

Authors:  Ying Ma; Min Yang; Haokao Gao; Gang Niu; Yongjun Yan; Lixin Lang; Dale O Kiesewetter; Xiaoyuan Chen
Journal:  Amino Acids       Date:  2012-02-22       Impact factor: 3.520

10.  Endoluminal ultrasound biomicroscopy as a reliable tool for in vivo assessment of colonic inflammation in rats.

Authors:  Marcelo Alexandre Pinto de Britto; Rossana Colla Soletti; Alberto Schanaider; Kalil Madi; Heitor Siffert Pereira de Souza; João Carlos Machado
Journal:  Int J Colorectal Dis       Date:  2013-08-08       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.